Get started
Author

Yusen Xiang

Observed name: Xiang, Yusen
ORCID: 0000-0003-1155-5469
Observed ORCID: 0000-0003-1155-5469
OpenAlex ID: A5028971768
Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
2021 · Jiacheng Xiong, Yusen Xiang, et al. · Frontiers in Chemistry · 26
PDF
Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
2021 · Yusen Xiang, Mengge Wang, et al. · Biochemical Pharmacology · 22
Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells
2022 · Mengge Wang, Yusen Xiang, et al. · Molecules · 20
PDF
Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay
2022 · Yusen Xiang, Guanglei Zhai, et al. · International Journal of Biological Macromolecules · 14
Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome ‐CoV ‐2 viruses through blocking virus invasion and antiinflammatory effect
2021 · Shaopeng Yu, Yao Chen, et al. · Phytotherapy Research · 14
PDF
FXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy
2023 · Danmei Yu, Zhou Lu, et al. · Biochemical Pharmacology · 6
Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay
2023 · Xiang, Yusen, Zhai, Guanglei, et al. · Zurich Open Repository and Archive (University of Zurich)
Works count: 8
Citation count: 102
H-index: 6
I10-index: 5
Year
Topic
Type